Back

Diabetes is associated with reduced survival in controls but not in patients with idiopathic pulmonary arterial hypertension

31 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Pulmonary hypertension and right ventricular Epidemiology, Prognosis, Outcome ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Associate Professor Barbro Kjellstrom

Skane University Hospital, Lund (Sweden)

5 More presentations in this session

Presentation thumbnail
Characterization of coronary microvascular dysfunction in patients with pulmonary hypertension
Doctor O. Velollari (Mainz, DE)
Abstract
Presentation thumbnail
Effects of high-intensity inspiratory muscle training on inspiratory muscle strength and exercise capacity in pulmonary arterial hypertension
Ms P. Wu (Taipei, TW)
Abstract
Presentation thumbnail
A CT echo triage model predicts markedly elevated pulmonary vascular resistance and right ventricular failure phenotype at catheterization
Doctor M. Al-Sarmi (Dublin, IE)
Abstract
Presentation thumbnail
Beyond hypocapnia: standardised capillary oxygen partial pressure predicts risk and treatment response in PAH
Mr T. Kramer (Cologne, DE)
Abstract
Presentation thumbnail
Phase 1 safety, tolerability, and pharmacokinetics of NS-863 supporting development for pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease
Professor Y. Tamura (Tokyo, JP)
Abstract

Access the full session

Session thumbnail
Pulmonary hypertension and right ventricular

The Event

Event poster

ESC Congress 2026

31 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Role of comorbidities and weight variations in the survival of diabetic patients with heart failure
13 June 2025
thumbnail
Congress Presentation
Health care utilization and productivity loss associated with pulmonary arterial hypertension: a Swedish nationwide register study
27 August 2022
thumbnail
Congress Presentation
Idiopathic pulmonary arterial hypertension, associated with connective tissue disease and comorbidities: prognostic differences? Results the Spanish Registry of pulmonary hypertension (REHAP Registry)
1 September 2024
thumbnail
Congress Presentation
Exploring the preventive role of GLP-1 receptor agonists in reducing pulmonary hypertension in diabetes: a multimodal analysis
3 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources